The burgeoning popularity of semaglutide, often recognized by brand names like copyright and Wegovy, has sparked significant discussion regarding its impact for fat loss. Initially created for treating type 2 diabetes, its significant tendency to promote fullness and lower appetite has led to its growing use—both recommended and sometimes off-lab